openPR Logo
Press release

Dabur Pharma Kalyani West Bengal signs MoU with BITS Pilani Rajasthan for HRD

12-27-2007 07:39 PM CET | Science & Education

Press release from: BITS Pilani

BITS Pilani VC exchanging MoU with Unit Head Dabur Pharma Kalyani

BITS Pilani VC exchanging MoU with Unit Head Dabur Pharma Kalyani

Birla Institute of Technology & Science (BITS), Pilani Rajasthan is a Deemed University (established under section 3 of the UGC Act. 1956 under notification no. F.12-23/63.U-2 dated 18th June, 1964) running educational programmes both on-campus as well as off-campus, offering degrees at all three-tiers, namely, Integrated First Degree, Higher Degree and Ph.D.

The Pharmacy Group of BITS, Pilani is one of the few early schools of Pharmacy in India. Established in 1950, under the able leadership of (Late) Prof. M. L. Schroff, Father of Pharmacy Education in India, it has blossomed into one of the most sought after Schools of Pharmacy in India.

Dabur Pharma Limited, Kalyani a public limited company incorporated in March 2003, is a leading Indian company for cancer research and anticancer products. Dabur Pharma Limited operates in Europe and in some other markets through its fully owned subsidiary- Dabur Oncology Plc.

The Memorandum of Understanding (MoU) between BITS and Dabur Pharma was signed on Friday, December 21, 2007 at Pilani with the objective of fostering collaboration between the two institutions to promote academic and research interactions for Industry-centric knowledge and skill upgradation. The MoU was signed by Prof L K Maheshwari Vice Chancellor on behalf of BITS Pilani and Dr Jayanta Chattopadhyay Unit Head on behalf of Dabur Pharma Kalyani.

BITS would operate an off-campus centre at Kalyani and run educational programs to meet the human resources development needs of Dabur Pharma leading to specific degrees of BITS through its Off-Campus Distance Learning & Collaborative Programs. These programs will have the same rigour and standards as those offered on-campus, and will be equivalent to the corresponding degrees offered on-campus.

The educational programmes conducted under this collaborative arrangement will offer the employees of Dabur Pharma India an opportunity to enhance their academic qualification and synergize theory and practice on a sustained basis so as to be multi-skilled with exposure to upcoming technological areas thus enabling them to appreciate key management concepts and participate better in organizational initiatives, improve their perspective, and provide meaningful insights.

A Coordination Committee consisting of Vice-Chancellor, BITS as Chairman, and two nominees each from Dabur Pharma and BITS would plan, coordinate and monitor the academic and research programmes as well as all related operational matters within the framework of the academic regulations of BITS and the objectives outlined by Dabur Pharma.

In India Today, this tie-up of BITS Pilani is yet another milestone in Industry University Collaborations.

Dr BR Natarajan
Professor & Dean
Birla Institute of Technology and Science
Pilani (Rajasthan) 333031 India
Phone 91-1596-242210
Fax 91-1596-244183
brnt@bits-pilani.ac.in
www.bits-pilani.ac.in

Birla Institute of Technology and Science (BITS), Pilani Rajasthan which has set a bench mark in industry university collaboration is one among the top ranking universities in India today offering degrees in various disciplines presently at Pilani, Dubai, Goa campuses and in the near future at Hyderabad campus apart from an array of work integrated learning programmes for HRD of a vast spectrum of Indian corporates.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Dabur Pharma Kalyani West Bengal signs MoU with BITS Pilani Rajasthan for HRD here

News-ID: 34437 • Views:

More Releases from BITS Pilani

Prof Nirupama from BITS Pilani invited to attend UNESCO International Mother Language Day Symposium at Paris
Prof Nirupama from BITS Pilani invited to attend UNESCO International Mother Lan …
It is known that we dissect nature along lines laid down by our native language and that language is not simply a reporting device for experience but a defining framework for it. Language is the armory of the human mind, and at once contains the trophies of its past and the weapons of its future conquests. No one has any doubt that language shapes the way we think, and determines
Groundbreaking Passion Quotient for Alma Mater by BITS Pilani 75-80 Batch Alumni
Groundbreaking Passion Quotient for Alma Mater by BITS Pilani 75-80 Batch Alumni
Alumni of BITS Pilani firmly believe that when a mission is taken up with passion, there are no dreams too large, no innovation unimaginable and no frontiers beyond reach. BITSians have always been known for their passion in whatever they do and the noble gesture by the BITS Alumni of 1975-80 batch goes to reiterate the same. This batch had their silver jubilee at Pilani in October 2005 and set
BITS Pilani Rajasthan Green and Sustainable Chemistry National Conference Concludes
BITS Pilani Rajasthan Green and Sustainable Chemistry National Conference Conclu …
There is no doubt that the issue in hand is all about maintaining a state of harmony between humans and nature and remembering Mahatma Gandhi's saying "There is a sufficiency in the world for man's need but not for man's greed." Green and sustainable chemistry is an important interdisciplinary area of innovation aimed at conservation of natural resources and the protection of environment. Sustainable development has become the accepted goal
Green Globe Foundation YUVA Award for BITS Pilani Chemical Engineering Student Raghav Mimani
Green Globe Foundation YUVA Award for BITS Pilani Chemical Engineering Student R …
It is known that Climate change not only impacts the ecology but has far-reaching consequences for the society, culture, and politics of the nations. Youth who bear the brunt of the negative impacts of climate change, also symbolize a great force in combating it and carry immense potential to be the flag bearers of change. Youth have the potential to be the change-makers, who through their knowledge, observations and action, can

All 5 Releases


More Releases for Pharma

Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031. The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031. The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis. Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382 The Indomethacin Global Market Research Report provides close monitoring
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024. Global Roxatidine Market overview: Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the